IRIS
TARAMASSO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.528
AS - Asia 1.775
NA - Nord America 825
SA - Sud America 152
AF - Africa 40
OC - Oceania 4
Totale 15.324
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.223
US - Stati Uniti d'America 777
SG - Singapore 725
CN - Cina 461
VN - Vietnam 394
FR - Francia 110
BR - Brasile 91
HK - Hong Kong 49
FI - Finlandia 48
DE - Germania 43
GB - Regno Unito 27
AR - Argentina 24
JP - Giappone 24
MX - Messico 23
IQ - Iraq 22
CA - Canada 18
NL - Olanda 13
ID - Indonesia 12
IN - India 12
BD - Bangladesh 11
PH - Filippine 11
ZA - Sudafrica 10
EC - Ecuador 9
CL - Cile 8
PK - Pakistan 8
CH - Svizzera 6
CO - Colombia 6
PY - Paraguay 6
SA - Arabia Saudita 6
SE - Svezia 6
UA - Ucraina 6
DZ - Algeria 5
RU - Federazione Russa 5
TN - Tunisia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ET - Etiopia 4
MA - Marocco 4
PE - Perù 4
PS - Palestinian Territory 4
RO - Romania 4
UZ - Uzbekistan 4
ES - Italia 3
GA - Gabon 3
GR - Grecia 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AT - Austria 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KR - Corea 2
MD - Moldavia 2
MT - Malta 2
PL - Polonia 2
RS - Serbia 2
SI - Slovenia 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 15.324
Salva come PNG Salva come JPEG
Città #
Genova 5.419
Genoa 4.367
Rapallo 1.163
Vado Ligure 1.143
Singapore 335
San Jose 253
Ashburn 168
Ho Chi Minh City 114
Hanoi 101
Lauterbourg 99
Council Bluffs 77
Beijing 67
Hong Kong 48
Helsinki 45
Bordighera 44
New York 38
Frankfurt am Main 32
St Louis 20
Haiphong 19
Tokyo 19
Da Nang 15
Orem 15
Santa Clara 15
Mexico City 13
Los Angeles 12
Tianjin 12
Baghdad 11
Biên Hòa 10
Rome 9
Montreal 8
São Paulo 8
London 7
Milan 7
Buffalo 6
Can Tho 6
Rio de Janeiro 6
Amsterdam 5
Asunción 5
Cardiff 5
City of London 5
Denver 5
Guangzhou 5
Jakarta 5
Johannesburg 5
Ninh Bình 5
Quảng Ngãi 5
Santiago 5
Stockholm 5
Toronto 5
Zurich 5
Addis Ababa 4
Atlanta 4
Bắc Ninh 4
Chicago 4
Guayaquil 4
Kyiv 4
Palermo 4
Shanghai 4
Amman 3
Ankara 3
Bogotá 3
Bắc Giang 3
Cape Town 3
Changsha 3
Dublin 3
Ha Long 3
Hải Dương 3
Jeddah 3
Lappeenranta 3
Libreville 3
Madrid 3
Marseille 3
Paris 3
Phủ Lý 3
Quận Ba 3
Sydney 3
Thái Nguyên 3
Tunis 3
Vĩnh Long 3
Athens 2
Bari 2
Belgrade 2
Boardman 2
Bra 2
Brasília 2
Brooklyn 2
Buon Ma Thuot 2
Bình Phước 2
Cairo 2
Calgary 2
Campinas 2
Cao Lanh 2
Casablanca 2
Charlotte 2
Chennai 2
Chisinau 2
Curitiba 2
Dhaka 2
Duhok 2
Go Vap 2
Totale 13.938
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 272
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 255
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 228
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 217
Bloodstream infections in patients living with HIV in the modern cART era 213
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 200
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 190
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 189
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 187
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 187
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 175
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 175
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 173
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 172
Bloodstream infections in critically ill patients with COVID-19 171
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 169
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 169
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 165
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 164
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 155
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 155
Will new antimicrobials overcome resistance among Gram-negatives? 154
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 154
Weight gain: A possible side effect of all antiretrovirals 153
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 150
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 145
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 144
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 143
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 142
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 141
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 139
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 138
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 137
Factors associated with hospital admission for COVID-19 in HIV patients 137
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 136
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 135
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 134
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 133
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 133
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 130
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 128
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 128
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 127
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 126
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 125
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 125
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 122
Onychomadesis in a male patient with secondary syphilis 121
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 119
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 119
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 119
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 118
Treatment of hepatitis C virus genotype 4 in the DAA era 117
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 117
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 116
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 116
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 115
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 115
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 113
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 113
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 113
Injectable Antiretroviral Drugs: Back to the Future 113
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 108
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 107
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 107
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 104
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 104
Bloodstream infections in HIV-infected patients 103
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 103
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 101
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 101
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 98
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 98
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 98
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 98
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 98
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 96
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 96
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 96
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 95
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 94
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 94
Aspetti medico sanitari, area infettivologica. In: Being Positive Strategie e Linguaggi per la comunicazione dell'HIV 93
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 93
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 92
CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders 90
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 88
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 87
Duration of isolation and precautions in immunocompromised patients with COVID-19 87
Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV 86
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 86
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 86
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 86
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 85
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 85
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 82
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 81
Totale 13.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.812
article - articoli 54.865
book - libri 0
conference - conferenze 1.217
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 292
Totale 113.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021347 0 0 0 0 0 0 0 0 0 130 65 152
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.434 119 115 11 130 175 195 64 105 209 109 178 24
2023/2024922 39 94 13 111 68 146 71 64 43 25 98 150
2024/20252.972 91 200 91 188 377 282 353 521 120 149 280 320
2025/20264.711 613 168 464 386 660 379 801 275 453 512 0 0
Totale 15.717